comparemela.com

Page 3 - Real World Evidence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ikerian AG, Parent Company of RetinAI U S Inc Announces Final Close of USD 6 18M (CHF 5 65M) Series A Extension Financing

Ikerian AG, Parent Company of RetinAI U S Inc Announces Final Close of USD 6 18M (CHF 5 65M) Series A Extension Financing
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans

Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.

Early Adherence to Glaucoma Medication Predicts Future Treatment Patterns

The national registry-based analysis in Denmark may inform the clinical value of medication adherence in the first years of glaucoma treatment.

RWE, HEOR, and Evidence Synthesis Practice at Axtria to Present at ISPOR 2024 Conference

RWE, HEOR, and Evidence Synthesis Practice at Axtria to Present at ISPOR 2024 Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Real-World Evidence/RWE Solutions Market Positioned to Achieve USD 5 8 Billion by 2033, Driven by 7

According to a recent report by Market.us, the Global Real World Evidence (RWE) Solutions Market size is expected to be worth around USD 5.8 Billion by 2033 from USD 2.7 Billion in 2023, growing at a CAGR of 7.9% during the forecast period from 2024 to 2033.An Increase in Demand and Opportunities for the Global Real.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.